HKEX: 1875
Interim report 2026
View original source (HKEXnews)
Earlier from Biodlink International
- BioDlink Named "Emerging CDMO of the Year" at the 2026 Asia-Pacific Biopharma Excellence Awards
- BioDlink Recognized by Client for Enabling the World's First Dual-Payload ADC to Enter Clinical Trials
- BioDlink Showcases Europe-China CMC Collaboration Amid Developmental Breakthrough
- BioDlink and Lepu Biopharma Celebrate Successful Launch of the World's First EGFR-Targeting ADC Drug, Marking a Major Milestone in Mutual Collaboration in Biologics CMC